Amundi lifted its holdings in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 7.6% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 672,171 shares of the company's stock after purchasing an additional 47,313 shares during the quarter. Amundi owned about 0.12% of UiPath worth $6,896,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Bank of Nova Scotia acquired a new stake in UiPath in the first quarter valued at approximately $3,907,000. Jump Financial LLC acquired a new position in shares of UiPath in the 1st quarter valued at $11,016,000. Deutsche Bank AG increased its holdings in shares of UiPath by 3.8% in the first quarter. Deutsche Bank AG now owns 1,562,306 shares of the company's stock valued at $16,092,000 after purchasing an additional 56,721 shares during the period. Clear Creek Financial Management LLC purchased a new position in UiPath in the 1st quarter valued at $266,000. Finally, Canada Pension Plan Investment Board grew its position in UiPath by 12.7% in the 1st quarter. Canada Pension Plan Investment Board now owns 1,809,200 shares of the company's stock valued at $18,635,000 after buying an additional 204,400 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.
Insider Transactions at UiPath
In other UiPath news, CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $12.01, for a total value of $540,450.00. Following the sale, the chief executive officer directly owned 2,700,133 shares in the company, valued at approximately $32,428,597.33. This trade represents a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders sold 876,310 shares of company stock valued at $10,969,372 in the last quarter. Company insiders own 23.19% of the company's stock.
UiPath Price Performance
Shares of PATH opened at $11.63 on Thursday. The business's fifty day moving average price is $11.70 and its 200 day moving average price is $11.79. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93. The stock has a market capitalization of $6.22 billion, a PE ratio of 387.50, a price-to-earnings-growth ratio of 4.55 and a beta of 1.02.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The firm had revenue of $361.73 million for the quarter, compared to analysts' expectations of $347.36 million. During the same period last year, the business posted $0.04 earnings per share. The firm's revenue for the quarter was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, research analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of research firms have commented on PATH. Canaccord Genuity Group reduced their target price on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a report on Monday. Zacks Research raised shares of UiPath from a "hold" rating to a "strong-buy" rating in a research note on Monday. Cowen reissued a "hold" rating on shares of UiPath in a research note on Friday, September 5th. Wall Street Zen raised shares of UiPath from a "buy" rating to a "strong-buy" rating in a research note on Saturday, September 6th. Finally, Barclays reaffirmed an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $13.18.
Check Out Our Latest Analysis on UiPath
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
